feed,title,long_url,short_url
Benzinga,"FDA Slams Break On Fulcrum Therapeutics' Sickle Cell Disease Study, Shares Plummet",https://benzinga.com/general/biotech/23/02/31049136/fda-slams-break-on-fulcrum-therapeutics-sickle-cell-disease-study-shares-plummet,https://da.gd/pfLj8
Benzinga,6 Domino's Pizza Analysts On Earnings: 'We Believe This Updated Financial Outlook Incorporates Ongoing Headwinds',https://benzinga.com/analyst-ratings/analyst-color/23/02/31049862/6-dominos-pizza-analysts-on-earnings-we-believe-this-updated-financial-outlook-inco,https://da.gd/rz7z3
